# Safety and Efficacy Predimenol for Headache

> **NCT06558006** · PHASE2 · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 60 (actual)

## Conditions studied

- Headache

## Interventions

- **DRUG:** Predimenol tablet
- **DRUG:** Predimenol tablet + Placebo tablet of Predimenol
- **DRUG:** Placebo tablet of Predimenol

## Key facts

- **NCT ID:** NCT06558006
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-19
- **Primary completion:** 2024-10-15
- **Final completion:** 2024-10-15
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06558006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06558006, "Safety and Efficacy Predimenol for Headache". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06558006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*